Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Journal of Environmental Management|May 23, 2013
Sustainability of a constructed wetland faced with a depredation eventM A Maine, H R Hadad, G C Sánchez, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|December 7, 2019
Non-HDL cholesterol as a therapeutic goalAngel Brea, Antonio Hernández-Mijares, Jesús Millán, et al.
Learning & Behavior|January 13, 2010
Serial position effects in social transmission of food preference: retention/demonstration intervalsBenjamin Melchor-Hipólito, Gustavo Meza-Reynoso, C Edith Juárez-Maldonado, et al.
European Journal of Cancer Care|January 6, 2016
Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL studyF Ramos, C Pedro, M Tormo, et al.
Dermatology (Basel, Switzerland)|November 13, 1998
Kaposi's sarcoma in a patient with erythroblastopenia and thymoma: reactivation after topical corticosteroidsE Pérez, M A Barnadas, V García-Patos, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 16, 2020
Complete pathological response (pCR) in gastroesophageal cancer: Correlation with metabolic responseF Cabral, A Cruz, R Casaca, et al.
Colloids and Surfaces. B, Biointerfaces|October 1, 2021
Intrinsically conductive polymers hybrid bilayer films for the fluorescence molecular diagnosis of the Zika virusKamila T O do Nascimento, Gabriela P Ratkovski, Graciela da C Pedro, et al.
Immunology Letters|December 22, 2015
Human neonates display altered ex vivo monokine production related to healthy adultsPaulo R Z Antas, Thaíze Q C Pedro, Eliana A Santiago, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|September 10, 2016
[Fibrates therapy: Rational use fenofibrate 2016. Executive summary]Angel Brea, Jesús Millán, Juan F Ascaso, et al.
Leukemia Research|April 24, 2012
Adverse impact of IDH1 and IDH2 mutations in primary AML: experience of the Spanish CETLAM groupJ Nomdedéu, M Hoyos, M Carricondo, et al.
Pageof 7